Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Ownership Summary
Crinetics Pharmaceuticals is owned by 70.04% institutional investors, 1.99% insiders, and 27.97% retail investors. Fmr is the largest institutional shareholder, holding 15.13% of CRNX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.15% of its assets in Crinetics Pharmaceuticals shares.
CRNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crinetics Pharmaceuticals | 70.04% | 1.99% | 27.97% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 14.19M | 15.13% | $590.91M |
| Vanguard group | 9.14M | 9.70% | $425.26M |
| Wellington management group llp | 8.38M | 8.94% | $349.11M |
| Blackrock | 6.23M | 8.62% | $279.06M |
| Blackrock funding, inc. /de | 7.99M | 8.48% | $371.87M |
| Driehaus capital management | 6.48M | 6.91% | $269.96M |
| Farallon capital management | 5.77M | 6.15% | $240.32M |
| Price t rowe associates inc /md/ | 5.31M | 5.66% | $221.01M |
| Ecor1 capital | 4.29M | 4.57% | $178.60M |
| Janus henderson group | 2.80M | 3.49% | $142.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 141.00K | 13.64% | $5.87M |
| Ecor1 capital | 4.29M | 8.57% | $178.60M |
| Novo | 1.63M | 4.36% | $67.68M |
| First light asset management | 941.52K | 3.70% | $39.21M |
| Checkpoint capital | 260.00K | 3.63% | $10.83M |
| Ghost tree capital | 240.00K | 3.37% | $10.75M |
| Paradigm biocapital advisors lp | 2.55M | 3.02% | $106.24M |
| Siren | 1.69M | 2.75% | $70.33M |
| Prosight management, lp | 262.90K | 2.53% | $12.24M |
| Driehaus capital management | 6.48M | 1.93% | $269.96M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 8.38M | 0.06% | 2.57M |
| Farallon capital management | 5.77M | 0.98% | 1.12M |
| Blackrock | 6.23M | 0.01% | 794.27K |
| Gw&k investment management | 1.48M | 0.59% | 625.78K |
| Ubs group | 908.19K | 0.01% | 500.47K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 2.21M | 0.00% | -1.02M |
| Jennison associates | 1.28M | 0.04% | -763.13K |
| Vestal point capital, lp | 750.00K | 1.41% | -750.00K |
| Lord, abbett | - | - | -724.63K |
| T. rowe price investment management | 60.58K | 0.00% | -655.59K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Impax asset management group | 275.00K | 0.08% | 275.00K | $12.80M |
| Checkpoint capital | 260.00K | 3.63% | 260.00K | $10.83M |
| Sio capital management | 174.84K | 1.84% | 174.84K | $7.28M |
| Rice hall james & associates | 174.08K | 0.40% | 174.08K | $7.25M |
| Sector gamma as | 115.00K | 1.22% | 115.00K | $5.35M |
Sold Out
| Holder | Change |
|---|---|
| Jpl wealth management | -5.00 |
| Twin peaks wealth advisors | -6.00 |
| Capital performance advisors llp | -8.00 |
| Cubist systematic strategies | -13.00 |
| Northwestern mutual wealth management | -16.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 204 | -13.92% | 65,989,147 | -38.74% | 70 | 0.53% | 119 | -9.85% | 63 | -11.27% |
| Sep 30, 2025 | 229 | 7.01% | 106,238,854 | 4.14% | 113 | 0.96% | 127 | 0.79% | 71 | 9.23% |
| Jun 30, 2025 | 219 | -2.67% | 104,541,979 | 7.66% | 111 | 1.02% | 129 | 3.20% | 64 | -11.11% |
| Mar 31, 2025 | 227 | -8.84% | 101,882,125 | 2.21% | 109 | 0.71% | 125 | -15.54% | 72 | 9.09% |
| Dec 31, 2024 | 243 | 2.53% | 99,207,040 | 17.39% | 123 | 1.11% | 144 | 18.03% | 66 | -12.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.23M | 3.15% | 258.68K |
| Vanguard Health Care Inv | 3.19M | 3.11% | -408.52K |
| Vanguard US Total Market Shares ETF | 2.40M | 2.58% | 2.45K |
| Fidelity OTC | 2.47M | 2.41% | 58.53K |
| iShares Russell 2000 ETF | 2.35M | 2.29% | 1.23M |
| Vanguard Small Cap Index | 2.32M | 2.27% | 172.22K |
| US Small-Cap Growth II Equity Comp | 1.49M | 1.46% | -178.66K |
| T. Rowe Price New Horizons | 1.49M | 1.46% | - |
| Vanguard Small Cap Growth Index Inv | 1.29M | 1.26% | 71.84K |
| Fidelity Select Health Care | 1.28M | 1.25% | -20.11K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 03, 2026 | Okey Stephanie | - | Sell | $119.01K |
| Mar 03, 2026 | Schilke Tobin | Chief Financial Officer | Sell | $266.30K |
| Jan 05, 2026 | Kalofonos Isabel | Chief Commercial Officer | Sell | $137.50K |
| Dec 01, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $225.10K |
| Nov 03, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $4.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 10 |
CRNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools